For prescribing information, click here

This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store.Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.

Resources

Paediatric Spasticity

Paediatric Spasticity - Resources
Paediatric Spasticity - Resources

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) therapeutic indications

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) is indicated for symptomatic treatment of focal spasticity of:

  • Dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older
  • Upper limbs in paediatric cerebral palsy patients, two years of age or older.

Please click here to see the full therapeutic indications.

Product Resources

Dilution Guide
Dilution Guide
PDF / PowerPoint Deck 2 pages

A reference guide to reconstituting and diluting Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) .

DYS-UK-009018 | November 2024
Reconstitution Guide
Reconstitution Guide
Video 10:03

How to prepare, reconstitute and store Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

DYS-UK-009047 | November 2024
Mechanism of Action of Botulinum Neurotoxin Type A
Mechanism of Action of Botulinum Neurotoxin Type A
Video 3:13

Short animation explaining the mechanism of action of botulinum neurotoxin type A

DYS-UK-009022 | November 2024

eLearning

Overview of Paediatric Spasticity – eLearning Module
Overview of Paediatric Spasticity – eLearning Module
PDF / PowerPoint Deck 41 pages

An overview of spasticity in children, including the classification of cerebral palsy and its consequences.

DYS-UK-009168 | November 2024
Goal Setting for Children with Spasticity
Goal Setting for Children with Spasticity
PDF / PowerPoint Deck 64 pages

An overview of goal setting for children with spasticity including the Canadian Occupation Performance Measure (COPM) and Goal Attainment Scaling (GAS).

DYS-UK-009106 | November 2024
Goal Setting in Spastic Paresis
Goal Setting in Spastic Paresis
Video 30:31

Presented by: Dr Nigar Dursun

DYS-UK-009243 | November 2024

Talking Head Videos

Demystifying the Clinical Relevance of BoNT Immunogenicity
Demystifying the Clinical Relevance of BoNT Immunogenicity
Video 06:00

Learn about the difference between neutralising and non-neutralising antibodies, and factors to consider when investigating non-response to BoNT treatment. Presented by: Dr Tim Harrower.

DYS-UK-009026 | November 2024

Contact your Ipsen representative

Send request
Resources